Exane Asset Management Merck & Co., Inc. Transaction History

Exane Asset Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 24, 2019	SELL	$76.08 - $82.93 $3.11 Million - $3.39 Million	-40,830 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$69.84 - $81.59 $772,430 - $902,385	11,060 Added 37.15%	40,830 $0
Q1 2019 May 07, 2019	BUY	$69.58 - $79.36 $2.07 Million - $2.36 Million	29,770 New	29,770 $0
Q4 2017 Feb 08, 2018	SELL	$51.62 - $61.64 $8.1 Million - $9.67 Million	-156,868 Closed	0 $0
Q3 2017 Oct 13, 2017	BUY	$58.67 - $63.13 $9.2 Million - $9.9 Million	156,868	156,868 $10 Billion

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Exane Asset Management, based on Form 13F filings with the SEC.

Stay updated on Exane Asset Management with notifications on news.